Press Releases

Opthea Presents Additional Data from Ph2b Trial at OIS in US

October 11, 2019

Read More

Opthea Presentation for Ophthalmology Innovation Summit

October 10, 2019

Read More

Opthea to Present at the Ophthalmology Innovation Summit in San Francisco

October 3, 2019

Read More

Opthea Receives A$14.6m R&D Tax Incentive

October 1, 2019

Read More

Opthea Presents Positive Data from OPT-302 Phase 2b Wet AMD Trial at EURETINA Congress

September 6, 2019

Read More

Opthea Presentation for EURETINA Congress

September 5, 2019

Read More

Opthea Ph2b of OPT-302 in wAMD to be Presented at EURETINA

September 4, 2019

Read More

Opthea Meets Primary Endpoint in Phase 2b Study of OPT-302 in Wet AMD

August 6, 2019

Read More

Opthea to Host Investor Teleconference

August 5, 2019

Read More

Opthea’s Patent Application Covering OPT-302 to be Granted by European Patent Office

July 30, 2019

Read More